Pharmaceutics International Data Breach Exposes PII

Pharmaceutics International, Inc., a leading contract development and manufacturing organization in the pharmaceutical industry, recently disclosed a significant data breach involving sensitive personally identifiable information (PII).

The incident was reported to the Massachusetts Attorney General’s office on Dec. 23, 2025. The breach exposed a wide range of sensitive information, including full names, Social Security numbers, dates of birth, current and previous addresses, government-issued identification cards, Social Security cards, pay stubs and W2 forms. So far, at least five resident of Massachusetts have been impacted. However, the investigation is ongoing and the number of impacted individuals is subject to change.

At this time, the company has not specified the exact method by which the breach occurred, nor has it attributed responsibility to a particular threat actor or cause. However, the range of data exposed makes this a severe incident with a high risk of identity-related crimes.

Pharmaceutics International's response

Immediately after learning of the incident, Pharmaceutics International, Inc. took steps to secure its systems and launched a comprehensive incident response. The company reviewed its security policies and procedures and is currently assessing its security measures to reduce the risk of similar events in the future. Relevant regulators have been notified as required by law. For those affected, the company is offering complimentary credit monitoring and identity protection services through Kroll.

If you receive notification from Pharmaceutics International or your provider about this breach, you may want to:

• Sign up for the free Kroll credit monitoring and identity theft protection services, offered by the company.
• Monitor your credit reports and financial accounts for any unusual activity.
• Be alert for phishing emails or phone calls that may use your exposed information.
• Consider placing a fraud alert or credit freeze with major credit bureaus.

For affected individuals with questions, Pharmaceutics International has set up a call center at 844-354-1388, Monday through Friday, 9 a.m. to 6:30 p.m. ET.